JP2023526790A5 - - Google Patents

Info

Publication number
JP2023526790A5
JP2023526790A5 JP2022569498A JP2022569498A JP2023526790A5 JP 2023526790 A5 JP2023526790 A5 JP 2023526790A5 JP 2022569498 A JP2022569498 A JP 2022569498A JP 2022569498 A JP2022569498 A JP 2022569498A JP 2023526790 A5 JP2023526790 A5 JP 2023526790A5
Authority
JP
Japan
Prior art keywords
administration
group
subject
substituted
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022569498A
Other languages
English (en)
Japanese (ja)
Other versions
JP7783834B2 (ja
JP2023526790A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/033495 external-priority patent/WO2021236985A1/en
Publication of JP2023526790A publication Critical patent/JP2023526790A/ja
Publication of JP2023526790A5 publication Critical patent/JP2023526790A5/ja
Application granted granted Critical
Publication of JP7783834B2 publication Critical patent/JP7783834B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022569498A 2020-05-21 2021-05-20 Tie-2の活性化物質による急性呼吸窮迫症候群の処置方法 Active JP7783834B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063028317P 2020-05-21 2020-05-21
US63/028,317 2020-05-21
PCT/US2021/033495 WO2021236985A1 (en) 2020-05-21 2021-05-20 Methods of treating acute respiratory distress syndrome with activators of tie-2

Publications (3)

Publication Number Publication Date
JP2023526790A JP2023526790A (ja) 2023-06-23
JP2023526790A5 true JP2023526790A5 (enExample) 2024-05-27
JP7783834B2 JP7783834B2 (ja) 2025-12-10

Family

ID=78707586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022569498A Active JP7783834B2 (ja) 2020-05-21 2021-05-20 Tie-2の活性化物質による急性呼吸窮迫症候群の処置方法

Country Status (7)

Country Link
US (1) US12544362B2 (enExample)
EP (1) EP4153237A4 (enExample)
JP (1) JP7783834B2 (enExample)
CN (1) CN115666651A (enExample)
AU (1) AU2021275224A1 (enExample)
CA (1) CA3177415A1 (enExample)
WO (1) WO2021236985A1 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2195958C1 (ru) * 2002-02-19 2003-01-10 Центральный научно-исследовательский институт туберкулеза РАМН Способ лечения синдрома острого повреждения легких после расширенных оперативных вмешательств
WO2004075838A2 (en) * 2003-02-21 2004-09-10 Rikshospitalet-Radiumhospitalet Hf Method and compositions for the treatment of meconium aspiration syndrome
WO2005034929A2 (en) * 2003-10-10 2005-04-21 Fibrogen, Inc. Tissue remodeling and vascularization
WO2007084136A2 (en) * 2006-01-23 2007-07-26 Ony, Inc. Treatment of acute respiratory distress syndrome
US9096555B2 (en) * 2009-01-12 2015-08-04 Aerpio Therapeutics, Inc. Methods for treating vascular leak syndrome
CA2838846C (en) 2009-01-12 2018-06-19 Aerpio Therapeutics Inc. Compositions and methods for treating brain edema
ES2743509T3 (es) * 2013-04-11 2020-02-19 Sunnybrook Res Inst Métodos, usos y composiciones de agonistas de Tie2
CN106456666A (zh) * 2014-01-10 2017-02-22 Ino治疗有限责任公司 使用吸入性一氧化氮气体来治疗儿童的急性呼吸窘迫综合征的方法
WO2017100796A1 (en) * 2015-12-11 2017-06-15 SINACA, Academia Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
WO2020214851A1 (en) * 2019-04-18 2020-10-22 Aerpio Pharmaceuticals, Inc. Methods of treating hypertension with activators of tie-2

Similar Documents

Publication Publication Date Title
JP4968868B2 (ja) 白血球数を高めるための方法および組成物
JP2024119812A5 (enExample)
JP2004508404A5 (enExample)
JP2016128481A (ja) 肺高血圧症の処置のためのニトロキシル供与体
RU2005128190A (ru) Ингибиторы фактора подавления миграции макрофагов (фпм) и способы их идентификации
RU2012153164A (ru) Производные мочевины и их терапевтическое применение при лечении, среди прочего, заболеваний дыхательного пути
ES2971959T3 (es) Terlipresina para el tratamiento de la ascitis debida a cirrosis hepática administrada como una infusión continua
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2025501309A5 (enExample)
US12064410B2 (en) Compositions and methods for stimulating ventilatory and/or respiratory
JP2025500826A5 (enExample)
EP2211868B1 (en) Silicate containing compositions for the treatment of melanoma
JP2023533162A5 (enExample)
FI3565551T3 (fi) Menetelmiä bakteeri-infektioiden hoitamiseksi vaborbaktaamin ja meropeneemin yhdistelmällä
JP2016506417A5 (enExample)
RU2008112181A (ru) Применение конденсированных производных имидазола для лечения заболеваний, опосредованных рецептором ccr3
JP2024540198A5 (enExample)
JP2024543345A5 (enExample)
JPS60208917A (ja) Ardsおよび多器官不全治療、予防におけるプロスタグランジンの使用
Rioja et al. Cardiorespiratory and minimum alveolar concentration sparing effects of a continuous intravenous infusion of dexmedetomidine in halothane or isoflurane-anaesthetized rats
US10543187B2 (en) Compositions and methods for stimulating ventilatory and/or respiratory drive
US20200206129A1 (en) Formulations for intravenous administration
US20250262181A1 (en) Compositions and methods for stimulating ventilatory and/or respiratory
JP4503835B2 (ja) 急性または成人型呼吸窮迫症候群(ards)および新生児呼吸窮迫症候群(irds)の治療のための、フェニルアミノチオフェン酢酸誘導体を含有する組成物
RU2823512C2 (ru) Способ проведения комбинированной анестезии при шунтирующих операциях у пациентов с портальной гипертензией